Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Genprex, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 39 | 36 | −3 |
| Shares | 6.61M | 5.04M | −1.57M (−23.8%) |
| Value | $2.61M | $1.16M | −$1.45M (−55.6%) |
New holders (7)
Institutions that held Genprex, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 359,500 | $83.0K | 0.00% |
| Squarepoint Ops LLC | 117,786 | $27.1K | 0.00% |
| Commonwealth Equity Services, LLC | 107,300 | $25.0K | 0.00% |
| Visionary Horizons, LLC | 30,000 | $6.90K | 0.01% |
| Millennium Management LLC | 28,226 | $6.49K | 0.00% |
| Kingsview Wealth Management, LLC | 21,000 | $4.83K | 0.00% |
| Tower Research Capital LLC (TRC) | 14,094 | $3.24K | 0.00% |
Sold out (10)
Institutions that held Genprex, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| AMH Equity Ltd | 813,135 | $321.1K |
| Cypress Capital, LLC | 100,000 | $39.5K |
| Virtu Financial LLC | 61,305 | $24.0K |
| Charles Schwab Investment Management Inc | 29,742 | $11.7K |
| Confluence Wealth Services, Inc. | 21,295 | $8.41K |
| XTX Topco Ltd | 20,298 | $8.02K |
| Cresset Asset Management, LLC | 17,000 | $6.71K |
| Eqis Capital Management, Inc. | 14,642 | $5.78K |
| Nemes Rush Group LLC | 10,000 | $3.95K |
| MCF Advisors LLC | 25 | $10 |